High unmet clinical needs in the emerging market, high patient awareness levels of patients and practitioners, increasing geriatric population and government initiatives impact the global ENT devices market.
The global ENT devices market is anticipated to reach USD 5.75 billion by 2024 from USD 3.58 billion in 2016, at a CAGR of 6.1% over the forecast period.
On the basis of product, hearing aids accounted for the largest market size among others at over USD 0.87 billion and hearing implants tends to dominate the ENT devices market over the forecast period. Flexible endoscopes accounted for nearly 40% of the ENT endoscopes market in 2016.
Browse Full Report: ENT Devices Market
Geographically, North America acquires the largest market with revenues in ENT device market estimated to reach USD 1.91 billion by 2024 at a CAGR of 5.2% over the forecast period.
New Comings: ENT Era of Innovation
Technologically advanced medical equipment, such as Phonak Audeo V by Sonova, bone-anchored hearing aids (BAHA) by Nobel Biocare, and micro hand instruments by Stema Medizin are expected to fuel ENT product folio. CS10 by Sound World Solutions is integrated with Bluetooth and iPhone, to amplify sound for nonhearing impaired consumers with its customized app. Provox 2 by Atos Medical Inc and Bloomsinger advantage by Inhealth Technologies are new innovative plus patient specific voice prosthesis equipment added by the companies to expand their voice reconstruction equipment portfolio.
“Global ENT Devices Market Outlook 2024” contains detailed overview of the global ENT devices market in terms of market segmentation by product and end user.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
Global ENT devices market report also provides competitive outlook for some of the major players which includes profiling of companies such as Sonova Holding AG, William Demant Holding A/S, Widex A/S, Siemens Healthcare, Cochlear Limited, Starkey Laboratories Inc., Rion Co., Ltd., Welch Allyn, GN ReSound A/S, and Atos Medical AB. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Overall, the report represents comprehensive synopsis on the global ENT devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.